Efficacy of combination of Viola odorata, Rosa damascena and Coriandrum sativum in prevention of migraine attacks

A randomized, double blind, placebo- controlled clinical trial

Authors

  • Haleh Tajadini Department of Persian Medicine, School of Persian Medicine, Kerman University of Medical Sciences, Kerman,Iran,MD, PhD ofPersianMedicine, Assistant Professor, Neurology Research Center, Kerman University of MedicalSciences, Kerman, Iran

Keywords:

Migraine; Headache; Viola; Coriandrum; Traditional medicine

Abstract

Background: Migraine is the second most common type of headache after tension headaches. In Iranian traditional medicine several herbal drugs are used for the treatment of headache. Including, a product of Iranian traditional medicine, a combination of Viola odorata L. flowers, Rosa damascena L. flowers and Coriandrum sativum L. fruits. Objective: To determine the effectiveness of a combination of Viola odorata flowers, Rosa damascene flowers and Coriandrum sativum fruits on severity, duration and frequency of migraine headaches. Methods: This randomized, double blind, placebo-controlled clinical trial was performed on 88 patients who had migraine and visited Besat Neurology Clinic No. 4 at Kerman University of Medical Sciences, Kerman, Iran, from September 2016 to march 2017. Patients were randomly divided into the intervention (n=44) or placebo group (n=44). The intervention group received a product of Iranian traditional medicine, a combination of Viola odorata L. flowers, Rosa damascena L. flowers and Coriandrum sativum L. fruits in 500 mg capsules three times a day and propranolol 20mg tablet twice a day, and the control group received placebo capsules (500mg) three times a day and propranolol 20mg tablet twice a day for four weeks. Patients were asked to report the frequency, duration and severity of their headaches in designed forms at home. Then at the end of the 2nd and 4th weeks of treatment, patients were followed for clinical efficacy. Results: In terms of duration, frequency and severity of headaches between the two groups of herbal medicine and placebo, the behavior of the two protocols was changed over time (p<0.001). During the 4 weeks, the time and drug interactions, were significant (p <0.001). In other words, the pattern of changes to the two protocols over time, was different. Also, at the end of the 4th week, there was a significant difference between the two groups (p<0.001). Conclusion: The study findings suggest that the Iranian traditional product combination of Viola odorata flowers, Rosa damascena flowers and Coriandrum sativum fruits may be effective in improving headaches in patients with migraine. Clinical trial registration: The trial was registered at the Iranian registry of clinical trials (IRCT: www.irct.ir) with registered NO. IRCT 2016110830776N1. Funding: The authors received no financial support for the research, authorship, and/or publication of this article.

References

Schramm S, Uluduz D, Gouveia RG, Jensen R, Siva A, Uygunoglu U, et al. Headache service quality:evaluation of quality indicators in 14 specialist-care centres. J Headache Pain. 2016; 17(1): 111. doi:10.1186/s10194-016-0707-9. PMID: 27933580, PMCID: PMC5145818.2)Huguet A, Tougas ME, Hayden J, McGrath PJ, Chambers CT, Stinson JN, et al. Systematic Review ofChildhood and Adolescent Risk and Prognostic Factors for Recurrent Headaches.J Pain. 2016; 17(8): 855-73. doi: 10.1016/j.jpain.2016.03.010. PMID: 27102894.3)Lee J, Bhowmick A, Wachholtz A. Does complementary and alternative medicine (CAM) use reducenegative life impact of headaches for chronic migraineurs? A national survey. Springerplus. 2016; 5(1):1006. doi: 10.1186/s40064-016-2362-7. PMID: 27398280, PMCID: PMC4937006.4)Darof RB, Fenichel GM, Jancovic J, Mazziotta JC. Bradley's Neurology in Clinical Practice. 2012; 2: 1715.5)Wang SJ, Chen PK, Fuh JL. Comorbidities of Migraine. Front Neurol. 2010; 1: 16. doi:10.3389/fneur.2010.00016. PMID: 21188255, PMCID: PMC3008936.6)Cady RK, Munjal S, Cady RJ, Manley HR, Brand-Schieber E. Randomized, double-blind, crossover studycomparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6mg subcutaneous sumatriptan for thetreatment of rapidly-escalating attacks of episodic migraine. J Headache Pain. 2017; 18(1): 17. doi:10.1186/s10194-016-0717-7. PMID: 28176235, PMCID: PMC5296269.7)Holroyd KA, Cottrell CK, O’Donnell FJ, Cordingley GE, Drew GB, Carlson BW, et al. Effect ofpreventive (β blocker) treatment, behavioural migraine management, or their combination on outcomes ofoptimised acute treatment in frequent migraine: randomised controlled trial. BMJ. 2010; 341: c4871. doi:10.1136/bmj.c4871.8)Garza I, Swanson JW, Cheshire WP, Boes CJ, Capobianco DJ, Vargas BB, et al. Headache and othercraniofacial pain. Bradley neurology in clinical practice. Philadelphia: Elsevier. 2012; 2: 1703-44. doi:10.1016/B978-1-4377-0434-1.00094-3.9)Uher R, Farmer A, Henigsberg N, Rietschel M, Mors O, Maier W, et al. Adverse reactions toantidepressants. Br J Psychiatry. 2009; 195(3): 202-10. doi: 10.1192/bjp.bp.108.061960. PMID: 19721108.10)Ramakrishnappa SK, Belhekar MN. Serum drug level-related sodium valproate-induced hair loss. Indian JPharmacol. 2013; 45(2): 187-8. doi: 10.4103/0253-7613.108315. PMID: 23716898, PMCID:PMC3660934.11)Miller S. The acute and preventative treatment of episodic migraine. Ann Indian Acad Neurol. 2012;15(Suppl 1): S33-9. doi: 10.4103/0972-2327.99998. PMID: 23024562, PMCID: PMC3444218.12)Adams J, Barbery G, Lui CW. Complementary and alternative medicine use for headache and migraine: acritical review of the literature. Headache. 2013; 53(3): 459-73. doi: 10.1111/j.1526-4610.2012.02271.x.PMID: 23078346.

Tajmirriahi M, Sohelipour M, Basiri K, Shaygannejad V, Ghorbani A, Saadatnia M. The effects of sodiumvalproate with fish oil supplementation or alone in migraine prevention: A randomized single-blind clinicaltrial. Iran J Neurol. 2012;11(1): 21-4. PMID: 24250854, PMCID: PMC3829229.14)Wells RE, Bertisch SM, Buettne C, Phillip RS, McCarthy EP. Complementary and alternative medicine useamong adults with migraines/severe headaches. Headache. 2011; 51(7): 1087-97. doi: 10.1111/j.1526-4610.2011.01917.x. PMID: 21649654, PMCID: PMC3627391.15)Headache Classification Committee of the International Headache Society (IHS). The InternationalClassification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33(9): 629-808. doi:10.1177/0333102413485658. PMID: 23771276.16)Burton A, Falkenberg T, Smith M, Zhang Q. WHO traditional medicine strategy 2014-2023. Availablefrom: http://www.who.int/medicines/publications/traditional/trm_strategy14_23/en/.17)Zargaran A, Borhani-Haghighi A, Faridi P, Daneshamouz S, Mohagheghzadeh A. A review on themanagement of migraine in the Avicenna's Canon of Medicine. Neurol Sci. 2016; 37(3): 471-8. doi:10.1007/s10072-016-2498-9. PMID: 26861565.18)Zarshenas MM, Petramfar P, Firoozabadi A, Moein MR, Mohagheghzadeh A. Types of headache and thoseremedies in traditional persian medicine. Pharmacogn Rev. 2013; 7(13): 17-26. doi: 10.4103/0973-7847.112835. PMID: 23922452, PMCID: PMC3731875.19)Gorji A. Pharmacological treatment of headache using traditional Persian medicine. Trends Pharmacol Sci.2003; 24(7): 331-4. doi: 10.1016/S0165-6147(03)00164-0. PMID: 12871664.20)Avicenna. The Cannon of Medicine. Tehran, Iran: Sorush Publication; 1983.21)Aghili Khorasani MH. Tehran: Tehran University of Medical Sciences; 2013.22)Chashti H. Exir-e-Azam. Tehran: Thran University of Medical Sciences, Institute for Islamic andComplementary Medicine. 2008.23)A’azam khan M. Gharabadin-e azam va akmal. Tehran: AL-Maei; 2014: 369.24)Karim khan kermani H. Daqaeq-al-AlajTehran: Chogan; 2016: 233.25)Antil V, Kumar P, Kannappan N, Diwan A, Saini P, Singh S. Evaluation of the analgesic activity of Violaodorata aerial parts in rats. Journal of Natural Pharmaceuticals. 2011; 2(1): 24-7.26)Monadi A, Rezaie A. Evaluation of sedative and pre-anesthetic effectsof Viola odorata Linn. Extractcompared with diazepam in rats. Bull Env Pharmacol Life Sci. 2013; 2(7): 125-31.27)Niazi M, Hashempur MH, Taghizadeh M, Heydari M, Shariat A. Efficacy of topical Rose (Rosa damascenaMill.) oil for migraine headache: A randomized double-blinded placebo-controlled cross-over trial.Complement Ther Med. 2017; 34: 35-41. doi: 10.1016/j.ctim.2017.07.009. PMID: 28917373.28)Hajhashemi V, Ghannadi A, Hajiloo M. Analgesic and anti-inflammatory effects of Rosa damascenahydroalcoholic extract and its essential oil in animal models. Iran J Pharm Res 2010; 9(2): 163-8. PMID:24363723, PMCID: PMC3862064.29)Rakhshandeh H, Vahdati-Mashhadian N, Dolati K, Hosseini M. Antinociceptive effect of Rosa damascenain Mice. J Biol Sci. 2008; 8: 176-80. doi: 10.3923/jbs.2008.176.180.30)Rakhshandah H, Hosseini M, Dolati K. Hypnotic Effect of Rosa damascena in Mice. Iranian Journal ofPharmaceutical Research. 2004; 3(3): 181-5.31)Delavar Kasmaei H, Ghorbanifar Z, Zayeri F, Minaei B, Kamali SH, Rezaeizadeh H, etal. Effects ofCoriandrum sativum Syrup on Migraine: A Randomized, Triple-Blind, Placebo-Controlled Trial. Iran RedCrescent Med J. 2016; 18(1): e20759. doi: 10.5812/ircmj.20759. PMID: 26889386, PMCID: PMC4752800.32)Mahdizadeh S, Khaleghi Ghadiri M, Gorji A.Avicenna's Canon of Medicine: a review of analgesics andanti-inflammatory substances. Avicenna J Phytomed. 2015; 5(3): 182-202. PMID: 26101752, PMCID:PMC4469963.33)Hamedi A, Zarshenas MM, Sohrabpour M, Zargaran A. Herbal medicinal oils in traditional Persianmedicine. Pharm Biol. 2013; 51(9): 1208-18. doi: 10.3109/13880209.2013.777462. PMID: 23746335.34)Bijur PE, Silver W, Gallagher EJ. Reliability of the Visual Analog Scale for Measurement of Acute Pain.Acad Emerg Med. 2001; 8(12): 1153-7. doi: 10.1111/j.1553-2712.2001.tb01132.x. PMID: 11733293.35)Fallah R, Divanizadeh MS, Karimi M, Mirouliaei M, Shamszadeh A. Topiramate and propranolol forprophylaxis of migraine. Indian J Pediatr. 2013; 80(11): 920-4. doi: 10.1007/s12098-013-0976-0. PMID:23412986.36)Feyzabadi Z, Jafari F, Kamali SH, Ashayeri H, Badiee Aval S, Esfahani MM, et al. Efficacy of Violaodorata in Treatment of Chronic Insomnia. Iran Red Crescent Med J. 2014; 16(12): e17511. doi:10.5812/ircmj.17511. PMID: 25763239, PMCID: PMC4341349

Published

2021-12-24

Issue

Section

Articles